| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lantern Pharma Inc. | Director | Stock Option (Right to Buy) | 18,460 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LTRN | Lantern Pharma Inc. | 09 Jan 2026 | 2 | $0 | 4 | Director | 13 Jan 2026, 16:05 |
| LTRN | Lantern Pharma Inc. | 19 Aug 2025 | 1 | $0 | 4 | Director | 20 Aug 2025, 18:25 |
| LTRN | Lantern Pharma Inc. | 24 Jul 2025 | 0 | $0 | 3 | Director | 30 Jul 2025, 17:20 |